載入...
Molecular Basis of Drug Resistance: Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Anaplastic Lymphoma Kinase Inhibitors
Over the past decade, several kinase inhibitors have been approved based on their clinical benefit in cancer patients. Unfortunately, in many cases, patients develop resistance to these agents via secondary mutations and alternative mechanisms. To date, several major mechanisms of acquired resistanc...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3861374/ https://ncbi.nlm.nih.gov/pubmed/24348666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4046/trd.2013.75.5.188 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|